Epigenetic silencing of PPARG in colorectal cancer may be a significant prognostic marker of tumor progression, and methylation on a specific region of the promoter is strongly correlated with PPARγ lack of expression in primary colorectal cancers and with patients' poor prognosis [26]. This evidence concerns the gene PPARG and neoplasm.